Maraviroc
Drug timelines are a Plus or Pro feature.
76 regulatory and trial events tracked for Maraviroc, covering 2009-06-04 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... [Phase 1, Phase 2]